查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1504935

全球罕見疾病診斷市場，佔有率，規模，趨勢，產業分析報告:各疾病類型，各產品類型，各樣品類型，各技術，試驗，各年齡層，各特性類型，各終端用戶，各地區，市場區隔預測，2024年-2032年

Global Rare Disease Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Disease Type; By Product Type; By Sample Type; By Technology; By Test; By Age Group; By Trait Type; By End-User; By Region; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，到2032年，全球罕見疾病診斷市場規模預計將達到889.6927億美元。該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

在技術快速進步和規模經濟推動下基因組定序的可用性和價格不斷提高等創新的推動下，罕見疾病診斷市場正在經歷強勁增長。隨著定序成本的持續下降和分析速度的提高，基因組測試將變得更加廣泛，使醫療保健提供者能夠為疑似罕見疾病患者提供全面的基因評估。

然而，這需要發現和驗證專門用於識別罕見疾病的新測試方法、生物標記和技術。研發投資推動創新，並能開發出更準確、更有效率、更具成本效益的測試解決方案。學術界、製藥公司和生技公司之間的合作對於增進科學理解並將發現轉化為實用的診斷工具至關重要。

罕見疾病治療和診斷工具的市場規模有限也導致了成本高昂。醫療保健組織、政策制定者和醫療利益相關者努力提高對罕見疾病經濟負擔的認識，並採取措施改善我所受影響的人獲得負擔得起的診斷測試和治療的機會。此外，技術進步和合作研究措施預計將在未來降低罕見疾病診斷的成本並提高效率。

全球罕見疾病診斷市場報告亮點

血液學和腫瘤學領域因其能夠準確、快速地檢測罕見的血液學和腫瘤學疾病而佔據市場主導地位，從而實現早期幹預和量身定制的治療方法。

由於罕見疾病檢測技術的進步可實現快速、準確的診斷，試劑盒和試劑行業預計將主導市場，並以最快的複合年增長率增長。

市場區隔憑藉最先進的基礎設施、先進的技術和熟練的診斷人員主導著市場。

由於對能夠準確識別和診斷罕見疾病的專業診斷服務的需求不斷增長，診斷實驗室行業預計將在預期期間表現出最高的複合年增長率。

由於基因檢測和精準醫學的進步，北美在該行業處於領先地位，並佔據了大部分市場收入佔有率，這在罕見疾病的診斷和治療中發揮關鍵作用。

目錄

第1章 簡介

第2章 利害關係者

第3章 摘要整理

第4章 調查手法

第5章 全球罕見疾病診斷市場洞察

  • 罕見疾病診斷-產業概述
  • 罕見疾病診斷市場動態
    • 促進因素和機會
      • 基因體技術的進步推動診斷創新
      • 由於認識提高，診斷需求增加
    • 阻礙因素與課題
      • 高成本
  • PESTEL分析
  • 罕見疾病診斷產業
  • 價值鏈分析
  • COVID-19影響分析

第6章 全球罕見疾病診斷市場:各疾病類型

  • 主要調查結果
  • 簡介
  • 消化器官疾病
  • 內分泌及代謝障礙
  • 心血管疾病
  • 肌肉骨骼障礙
  • 神經疾病
  • 血液學及腫瘤學疾病
  • 皮膚科疾病
  • 其他

第7章 全球罕見疾病診斷市場:各產品類型

  • 主要調查結果
  • 簡介
  • 套件和試劑
  • 設備
  • 軟體

第8章 全球罕見疾病診斷市場:各樣品類型

  • 主要調查結果
  • 簡介
  • 血液樣品
  • 頰黏膜拭子樣本
  • 其他

第9章 全球罕見疾病診斷市場:各技術

  • 主要調查結果
  • 簡介
  • 次世代定序
  • 全EXOME
  • 全基因
  • 陣列科技
  • PCR為基礎的檢驗
  • FISH
  • Sanger序列
  • 染色體組型分析

第10章 全球罕見疾病診斷市場:檢查別

  • 主要調查結果
  • 簡介
  • 遺傳基因檢驗
  • 一般的臨床檢驗
  • 影像檢查

第11章 全球罕見疾病診斷市場: 各年齡層

  • 主要調查結果
  • 簡介
  • 大人
  • 兒童

第12章 全球罕見疾病診斷市場:各特性類型

  • 主要調查結果
  • 簡介
  • 遺傳性
  • 後天性

第13章 全球罕見疾病診斷市場:各最終用途

  • 主要調查結果
  • 簡介
  • 調查機關和CRO
  • 醫院·診所
  • 診斷檢驗室

第14章 全球罕見疾病診斷市場:地區

  • 主要調查結果
  • 簡介
    • 罕見疾病診斷市場評估:地區，2019年～2032年
  • 北美
    • 北美:各疾病類型，2019年～2032年
    • 北美:各技術，2019年～2032年
    • 北美:各產品類型，2019年～2032年
    • 北美:試驗，2019年～2032年
    • 北美:各樣品類型，2019年～2032年
    • 北美:各年齡層，2019年～2032年
    • 北美:各特性類型，2019年～2032年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:各疾病類型，2019年～2032年
    • 歐洲:各技術，2019年～2032年
    • 歐洲:各產品類型，2019年～2032年
    • 歐洲:試驗，2019年～2032年
    • 歐洲:各樣品類型，2019年～2032年
    • 歐洲:各年齡層，2019年～2032年
    • 歐洲:各特性類型，2019年～2032年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
  • 亞太地區
    • 亞太地區:各疾病類型，2019年～2032年
    • 亞太地區:各技術，2019年～2032年
    • 亞太地區:各產品類型，2019年～2032年
    • 亞太地區:試驗，2019年～2032年
    • 亞太地區:各樣品類型，2019年～2032年
    • 亞太地區:各年齡層，2019年～2032年
    • 亞太地區:各特性類型，2019年～2032年
    • 中國
    • 印度
    • 日本
    • 馬來西亞
    • 印尼
    • 韓國
  • 中東·非洲
    • 中東及非洲:各疾病類型，2019年～2032年
    • 中東·非洲:各技術，2019年～2032年
    • 中東及非洲:各產品類型，2019年～2032年
    • 中東及非洲:試驗，2019年～2032年
    • 中東及非洲:各樣品類型，2019年～2032年
    • 中東·非洲:各年齡層，2019年～2032年
    • 中東及非洲:各特性類型，2019年～2032年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
  • 南美
    • 南美:各疾病類型，2019年～2032年
    • 南美:各技術，2019年～2032年
    • 南美:各產品類型，2019年～2032年
    • 南美:試驗，2019年～2032年
    • 南美:各樣品類型，2019年～2032年
    • 南美:各年齡層，2019年～2032年
    • 南美:各特性類型，2019年～2032年
    • 墨西哥
    • 巴西
    • 阿根廷

第15章 競爭情形

  • 擴大和收購的分析
    • 擴大
    • 收購
  • 聯盟/合作/協定/公開

第16章 企業簡介

  • 3billion, Inc.
  • Agilent Technologies, Inc
  • CENTOGENE N.V
  • F. Hoffmann-La Roche Ltd
  • FDNA(TM)INC
  • GeneDx, LLC
  • Illumina, Inc.
  • Invitae Corporation
  • Novo Nordisk A/S
  • Quest Diagnostics
Product Code: PM4902

The global rare disease diagnostics market size is expected to reach USD 88,969.27 million by 2032, according to a new study by Polaris Market Research. The report "Global Rare Disease Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Disease Type; By Product Type; By Sample Type; By Technology; By Test; By Age Group; By Trait Type; By End-User; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rare disease diagnostics market is experiencing robust growth, driven by innovation is the increasing accessibility and affordability of genomic sequencing, facilitated by rapid technological advancements and economies of scale. As the cost of sequencing continues to decline and the speed of analysis improves, genomic testing has become more widely available, enabling healthcare providers to offer comprehensive genetic evaluations to patients with suspected rare diseases.

However, this involves the discovery and validation of novel testing methods, biomarkers, and technologies tailored for identifying rare diseases. Investments in R&D drive innovation, enabling the development of more accurate, efficient, and cost-effective testing solutions. Collaboration between academia, pharmaceutical companies, and biotech firms is crucial in advancing scientific understanding and translating discoveries into practical diagnostic tools.

The limited market size for treatments and diagnostic tools targeting rare diseases also contributes to their high cost. Advocacy organizations, policymakers, and healthcare stakeholders are working to raise awareness of the economic burden of rare diseases and implement measures to improve access to affordable diagnostic testing and treatments for affected individuals. Additionally, advancements in technology and collaborative research initiatives hold promise for driving down costs and improving the efficiency of rare disease diagnosis in the future.

Global Rare Disease Diagnostics Market Report Highlights

The Hematology and Oncology disease segment dominated the market owing to the precise and prompt detection of rare blood and oncological conditions, which led to early intervention and tailored treatment approaches.

The Kits and Reagents segment dominated and is anticipated to grow at the fastest CAGR owing to advancements in the detection of rare diseases, which enable quicker and more precise diagnosis.

The Research Laboratories and Cros segment dominated the market owing to cutting-edge infrastructure, advanced technologies, and skilled personnel for diagnostic purposes.

The Diagnostics Laboratories segment is expected to witness the highest CAGR over the anticipated period due to a rise in demand for specialized diagnostic services that can accurately identify and diagnose rare diseases.

North America led the industry and accounted for a majority of market revenue share owing to the progress made in genetic testing and precision medicine, which play crucial roles in diagnosing and treating rare conditions.

The global key market players include CENTOGENE N.V., F. Hoffmann-La Roche Ltd., FDNA(TM) INC, GeneDx, LLC, Illumina, Inc., Invitae Corporation, Novo Nordisk A/S, Quest Diagnostics, etc.

Polaris Market Research has segmented the global rare disease diagnostics market report based on disease type, product type, sample type, technology, test, age group, trait type, end-user, and region:

Global Rare Disease Diagnostics, Disease Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Gastroenterology Disease
  • Endocrine and Metabolism Disorders Disease
  • Cardiovascular Disorders
  • Musculoskeletal Disorders
  • Neurology Disease
  • Hematology and Oncology Disease
  • Dermatology Disease
  • Others

Global Rare Disease Diagnostics, Product Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Kits & Reagents
  • Instruments
  • Software

Global Rare Disease Diagnostics, Sample Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Blood Sample
  • Buccal Swab Sample
  • Others

Global Rare Disease Diagnostics, Technology Outlook (Revenue - USD Billion, 2019 - 2032)

  • Next Generation Sequencing
  • Whole Exome
  • Whole Genome
  • Array Technology
  • PCR Based Testing
  • FISH
  • Sanger Sequencing
  • Karyotyping

Global Rare Disease Diagnostics, Test Outlook (Revenue - USD Million, 2019 - 2032)

  • Genetic Test
  • General Lab Test
  • Imaging Test

Global Rare Disease Diagnostics, Age Group Outlook (Revenue - USD Million, 2019 - 2032)

  • Children
  • Adult

Global Rare Disease Diagnostics, Trait Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Inherited
  • Acquired

Global Rare Disease Diagnostics, End- Use Outlook (Revenue - USD Million, 2019 - 2032)

  • Research Laboratories & Cros
  • Hospitals & Clinics
  • Diagnostic Laboratories

Global Rare Disease Diagnostics, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Australia
  • Malaysia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions

2. Stakeholders

3. Executive Summary

  • 3.1. Market Highlights

4. Research Methodology

  • 4.1. Overview
    • 4.1.1. Data Mining
  • 4.2. Data Sources
    • 4.2.1. Primary Sources
    • 4.2.2. Secondary Sources

5. Global Rare Disease Diagnostics Market Insights

  • 5.1. Rare Disease Diagnostics - Industry Snapshot
  • 5.2. Rare Disease Diagnostics Market Dynamics
    • 5.2.1. Drivers and Opportunities
      • 5.2.1.1. Advances in genomic technologies drive diagnostic innovation
      • 5.2.1.2. Increasing awareness leads to higher demand for diagnostics
    • 5.2.2. Restraints and Challenges
      • 5.2.2.1. High costs
    • 5.2.3. Porter's Five Forces Analysis
      • 5.2.3.1. Bargaining Power of Suppliers (Moderate)
      • 5.2.3.2. Threats of New Entrants (Low)
      • 5.2.3.3. Bargaining Power of Buyers (Moderate)
      • 5.2.3.4. Threat of Substitute (Moderate)
      • 5.2.3.5. Rivalry among Existing Firms (High)
  • 5.3. PESTEL Analysis
  • 5.4. Rare Disease Diagnostics Industry
  • 5.5. Value Chain Analysis
  • 5.6. COVID-19 Impact Analysis

6. Global Rare Disease Diagnostics Market, by Disease Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
  • 6.3. Gastroenterology Disease
    • 6.3.1. Global Rare Disease Diagnostics Market, by Gastroenterology Disease, by Region, 2019-2032 (USD Million)
  • 6.4. Endocrine and Metabolism Disorders Disease
    • 6.4.1. Global Rare Disease Diagnostics Market, by Endocrine and Metabolism Disorders Disease, by Region, 2019-2032 (USD Million)
  • 6.5. Cardiovascular Disorders
    • 6.5.1. Global Rare Disease Diagnostics Market, by Cardiovascular Disorders, by Region, 2019-2032 (USD Million)
  • 6.6. Musculoskeletal Disorders
    • 6.6.1. Global Rare Disease Diagnostics Market, by Musculoskeletal Disorders, by Region, 2019-2032 (USD Million)
  • 6.7. Neurology Disease
    • 6.7.1. Global Rare Disease Diagnostics Market, by Neurology Disease, by Region, 2019-2032 (USD Million)
  • 6.8. Hematology and Oncology Disease
    • 6.8.1. Global Rare Disease Diagnostics Market, by Hematology and Oncology Disease, by Region, 2019-2032 (USD Million)
  • 6.9. Dermatology Disease
    • 6.9.1. Global Rare Disease Diagnostics Market, by Dermatology Disease, by Region, 2019-2032 (USD Million)
  • 6.10. Others
    • 6.10.1. Global Rare Disease Diagnostics Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Rare Disease Diagnostics Market, by Mode of Product Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
  • 7.3. Kits & Reagents
    • 7.3.1. Global Rare Disease Diagnostics Market, by Kits & Reagents, by Region, 2019-2032 (USD Million)
  • 7.4. Instruments
    • 7.4.1. Global Rare Disease Diagnostics Market, by Instruments, by Region, 2019-2032 (USD Million)
  • 7.5. Software
    • 7.5.1. Global Rare Disease Diagnostics Market, by Software, by Region, 2019-2032 (USD Million)

8. Global Rare Disease Diagnostics Market, by Sample Type

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
  • 8.3. Blood Sample
    • 8.3.1. Global Rare Disease Diagnostics Market, by Blood Sample, by Region, 2019-2032 (USD Million)
  • 8.4. Buccal Swab Sample
    • 8.4.1. Global Rare Disease Diagnostics Market, by Buccal Swab Sample, by Region, 2019-2032 (USD Million)
  • 8.5. Others
    • 8.5.1. Global Rare Disease Diagnostics Market, by Others, by Region, 2019-2032 (USD Million)

9. Global Rare Disease Diagnostics Market, by Technology

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • 9.3. Next Generation Sequencing
    • 9.3.1. Global Rare Disease Diagnostics Market, by Next Generation Sequencing, by Region, 2019-2032 (USD Million)
  • 9.4. Whole Exome
    • 9.4.1. Global Rare Disease Diagnostics Market, by Whole Exome, by Region, 2019-2032 (USD Million)
  • 9.5. Whole Genome
    • 9.5.1. Global Rare Disease Diagnostics Market, by Whole Genome, by Region, 2019-2032 (USD Million)
  • 9.6. Array Technology
    • 9.6.1. Global Rare Disease Diagnostics Market, by Array Technology, by Region, 2019-2032 (USD Million)
  • 9.7. PCR Based Testing
    • 9.7.1. Global Rare Disease Diagnostics Market, by PCR Based Testing, by Region, 2019-2032 (USD Million)
  • 9.8. FISH
    • 9.8.1. Global Rare Disease Diagnostics Market, by FISH, by Region, 2019-2032 (USD Million)
  • 9.9. Sanger Sequencing
    • 9.9.1. Global Rare Disease Diagnostics Market, by Sanger Sequencing, by Region, 2019-2032 (USD Million)
  • 9.10. Karyotyping
    • 9.10.1. Global Rare Disease Diagnostics Market, by Karyotyping, by Region, 2019-2032 (USD Million)

10. Global Rare Disease Diagnostics Market, by Test

  • 10.1. Key Findings
  • 10.2. Introduction
    • 10.2.1. Global Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
  • 10.3. Genetic Test
    • 10.3.1. Global Rare Disease Diagnostics Market, by Genetic Test, by Region, 2019-2032 (USD Million)
  • 10.4. General Lab Test
    • 10.4.1. Global Rare Disease Diagnostics Market, by General Lab Test, by Region, 2019-2032 (USD Million)
  • 10.5. Imaging Test
    • 10.5.1. Global Rare Disease Diagnostics Market, by Imaging Test, by Region, 2019-2032 (USD Million)

11. Global Rare Disease Diagnostics Market, by Age Group

  • 11.1. Key Findings
  • 11.2. Introduction
    • 11.2.1. Global Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
  • 11.3. Adult
    • 11.3.1. Global Rare Disease Diagnostics Market, by Adult, by Region, 2019-2032 (USD Million)
  • 11.4. Children
    • 11.4.1. Global Rare Disease Diagnostics Market, by Children, by Region, 2019-2032 (USD Million)

12. Global Rare Disease Diagnostics Market, by Trait Type

  • 12.1. Key Findings
  • 12.2. Introduction
    • 12.2.1. Global Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • 12.3. Inherited
    • 12.3.1. Global Rare Disease Diagnostics Market, by Inherited, by Region, 2019-2032 (USD Million)
  • 12.4. Acquired
    • 12.4.1. Global Rare Disease Diagnostics Market, by Acquired, by Region, 2019-2032 (USD Million)

13. Global Rare Disease Diagnostics Market, by End-Use

  • 13.1. Key Findings
  • 13.2. Introduction
    • 13.2.1. Global Rare Disease Diagnostics Market, by End-Use, 2019-2032 (USD Million)
  • 13.3. Research Laboratories & CROs
    • 13.3.1. Global Rare Disease Diagnostics Market, by Research Laboratories & CROs, by Region, 2019-2032 (USD Million)
  • 13.4. Hospitals & Clinics
    • 13.4.1. Global Rare Disease Diagnostics Market, by Hospitals & Clinics, by Region, 2019-2032 (USD Million)
  • 13.5. Diagnostic Laboratories
    • 13.5.1. Global Rare Disease Diagnostics Market, by Diagnostic Laboratories, by Region, 2019-2032 (USD Million)

14. Global Rare Disease Diagnostics Market, by Geography

  • 14.1. Key Findings
  • 14.2. Introduction
    • 14.2.1. Rare Disease Diagnostics Market Assessment, By Geography, 2019-2032 (USD Million)
  • 14.3. Rare Disease Diagnostics Market - North America
    • 14.3.1. North America: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
    • 14.3.2. North America: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 14.3.3. North America: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
    • 14.3.4. North America: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
    • 14.3.5. North America: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
    • 14.3.6. North America: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
    • 14.3.7. North America: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.3.8. Rare Disease Diagnostics Market - U.S.
      • 14.3.8.1. U.S.: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.3.8.2. U.S.: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.3.8.3. U.S.: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.3.8.4. U.S.: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.3.8.5. U.S.: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.3.8.6. U.S.: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.3.8.7. U.S.: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.3.9. Rare Disease Diagnostics Market - Canada
      • 14.3.9.1. Canada: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.3.9.2. Canada: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.3.9.3. Canada: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.3.9.4. Canada: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.3.9.5. Canada: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.3.9.6. Canada: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.3.9.7. Canada: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • 14.4. Rare Disease Diagnostics Market - Europe
    • 14.4.1. Europe: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
    • 14.4.2. Europe: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 14.4.3. Europe: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
    • 14.4.4. Europe: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
    • 14.4.5. Europe: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
    • 14.4.6. Europe: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
    • 14.4.7. Europe: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.4.8. Rare Disease Diagnostics Market - UK
      • 14.4.8.1. UK: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.4.8.2. UK: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.4.8.3. UK: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.4.8.4. UK: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.4.8.5. UK: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.4.8.6. UK: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.4.8.7. UK: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.4.9. Rare Disease Diagnostics Market - France
      • 14.4.9.1. France: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.4.9.2. France: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.4.9.3. France: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.4.9.4. France: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.4.9.5. France: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.4.9.6. France: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.4.9.7. France: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.4.10. Rare Disease Diagnostics Market - Germany
      • 14.4.10.1. Germany: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.4.10.2. Germany: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.4.10.3. Germany: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.4.10.4. Germany: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.4.10.5. Germany: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.4.10.6. Germany: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.4.10.7. Germany: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.4.11. Rare Disease Diagnostics Market - Italy
      • 14.4.11.1. Italy: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.4.11.2. Italy: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.4.11.3. Italy: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.4.11.4. Italy: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.4.11.5. Italy: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.4.11.6. Italy: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.4.11.7. Italy: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.4.12. Rare Disease Diagnostics Market - Spain
      • 14.4.12.1. Spain: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.4.12.2. Spain: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.4.12.3. Spain: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.4.12.4. Spain: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.4.12.5. Spain: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.4.12.6. Spain: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.4.12.7. Spain: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.4.13. Rare Disease Diagnostics Market - Netherlands
      • 14.4.13.1. Netherlands: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.4.13.2. Netherlands: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.4.13.3. Netherlands: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.4.13.4. Netherlands: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.4.13.5. Netherlands: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.4.13.6. Netherlands: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.4.13.7. Netherlands: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.4.14. Rare Disease Diagnostics Market - Russia
      • 14.4.14.1. Russia: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.4.14.2. Russia: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.4.14.3. Russia: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.4.14.4. Russia: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.4.14.5. Russia: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.4.14.6. Russia: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.4.14.7. Russia: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • 14.5. Rare Disease Diagnostics Market - Asia Pacific
    • 14.5.1. Asia Pacific: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
    • 14.5.2. Asia Pacific: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 14.5.3. Asia Pacific: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
    • 14.5.4. Asia Pacific: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
    • 14.5.5. Asia Pacific: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
    • 14.5.6. Asia Pacific: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
    • 14.5.7. Asia Pacific: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.5.8. Rare Disease Diagnostics Market - China
      • 14.5.8.1. China: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.5.8.2. China: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.5.8.3. China: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.5.8.4. China: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.5.8.5. China: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.5.8.6. China: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.5.8.7. China: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.5.9. Rare Disease Diagnostics Market - India
      • 14.5.9.1. India: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.5.9.2. India: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.5.9.3. India: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.5.9.4. India: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.5.9.5. India: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.5.9.6. India: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.5.9.7. India: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.5.10. Rare Disease Diagnostics Market - Japan
      • 14.5.10.1. Japan: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.5.10.2. Japan: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.5.10.3. Japan: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.5.10.4. Japan: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.5.10.5. Japan: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.5.10.6. Japan: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.5.10.7. Japan: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.5.11. Rare Disease Diagnostics Market - Malaysia
      • 14.5.11.1. Malaysia: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.5.11.2. Malaysia: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.5.11.3. Malaysia: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.5.11.4. Malaysia: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.5.11.5. Malaysia: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.5.11.6. Malaysia: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.5.11.7. Malaysia: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.5.12. Rare Disease Diagnostics Market - Indonesia
      • 14.5.12.1. Indonesia: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.5.12.2. Indonesia: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.5.12.3. Indonesia: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.5.12.4. Indonesia: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.5.12.5. Indonesia: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.5.12.6. Indonesia: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.5.12.7. Indonesia: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.5.13. Rare Disease Diagnostics Market - South Korea
      • 14.5.13.1. South Korea: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.5.13.2. South Korea: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.5.13.3. South Korea: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.5.13.4. South Korea: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.5.13.5. South Korea: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.5.13.6. South Korea: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.5.13.7. South Korea: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • 14.6. Rare Disease Diagnostics Market - Middle East & Africa
    • 14.6.1. Middle East & Africa: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
    • 14.6.2. Middle East & Africa: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 14.6.3. Middle East & Africa: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
    • 14.6.4. Middle East & Africa: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
    • 14.6.5. Middle East & Africa: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
    • 14.6.6. Middle East & Africa: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
    • 14.6.7. Middle East & Africa: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.6.8. Rare Disease Diagnostics Market - Saudi Arabia
      • 14.6.8.1. Saudi Arabia: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.6.8.2. Saudi Arabia: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.6.8.3. Saudi Arabia: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.6.8.4. Saudi Arabia: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.6.8.5. Saudi Arabia: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.6.8.6. Saudi Arabia: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.6.8.7. Saudi Arabia: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.6.9. Rare Disease Diagnostics Market - UAE
      • 14.6.9.1. UAE: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.6.9.2. UAE: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.6.9.3. UAE: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.6.9.4. UAE: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.6.9.5. UAE: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.6.9.6. UAE: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.6.9.7. UAE: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.6.10. Rare Disease Diagnostics Market - Israel
      • 14.6.10.1. Israel: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.6.10.2. Israel: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.6.10.3. Israel: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.6.10.4. Israel: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.6.10.5. Israel: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.6.10.6. Israel: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.6.10.7. Israel: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.6.11. Rare Disease Diagnostics Market - South Africa
      • 14.6.11.1. South Africa: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.6.11.2. South Africa: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.6.11.3. South Africa: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.6.11.4. South Africa: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.6.11.5. South Africa: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.6.11.6. South Africa: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.6.11.7. South Africa: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • 14.7. Rare Disease Diagnostics Market - Latin America
    • 14.7.1. Latin America: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
    • 14.7.2. Latin America: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 14.7.3. Latin America: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
    • 14.7.4. Latin America: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
    • 14.7.5. Latin America: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
    • 14.7.6. Latin America: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
    • 14.7.7. Latin America: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.7.8. Rare Disease Diagnostics Market - Mexico
      • 14.7.8.1. Mexico: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.7.8.2. Mexico: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.7.8.3. Mexico: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.7.8.4. Mexico: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.7.8.5. Mexico: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.7.8.6. Mexico: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.7.8.7. Mexico: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.7.9. Rare Disease Diagnostics Market - Brazil
      • 14.7.9.1. Brazil: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.7.9.2. Brazil: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.7.9.3. Brazil: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.7.9.4. Brazil: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.7.9.5. Brazil: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.7.9.6. Brazil: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.7.9.7. Brazil: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.7.10. Rare Disease Diagnostics Market - Argentina
      • 14.7.10.1. Argentina: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.7.10.2. Argentina: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.7.10.3. Argentina: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.7.10.4. Argentina: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.7.10.5. Argentina: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.7.10.6. Argentina: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.7.10.7. Argentina: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)

15. Competitive Landscape

  • 15.1. Expansion and Acquisition Analysis
    • 15.1.1. Expansion
    • 15.1.2. Acquisitions
  • 15.2. Partnerships/Collaborations/Agreements/Exhibitions

16. Company Profiles

  • 16.1. 3billion, Inc.
    • 16.1.1. Company Overview
    • 16.1.2. Financial Performance
    • 16.1.3. Product Benchmarking
    • 16.1.4. Recent Development
  • 16.2. Agilent Technologies, Inc
    • 16.2.1. Company Overview
    • 16.2.2. Financial Performance
    • 16.2.3. Product Benchmarking
    • 16.2.4. Recent Development
  • 16.3. CENTOGENE N.V
    • 16.3.1. Company Overview
    • 16.3.2. Financial Performance
    • 16.3.3. Product Benchmarking
    • 16.3.4. Recent Development
  • 16.4. F. Hoffmann-La Roche Ltd
    • 16.4.1. Company Overview
    • 16.4.2. Financial Performance
    • 16.4.3. Product Benchmarking
    • 16.4.4. Recent Development
  • 16.5. FDNA(TM) INC
    • 16.5.1. Company Overview
    • 16.5.2. Financial Performance
    • 16.5.3. Product Benchmarking
    • 16.5.4. Recent Development
  • 16.6. GeneDx, LLC
    • 16.6.1. Company Overview
    • 16.6.2. Financial Performance
    • 16.6.3. Product Benchmarking
    • 16.6.4. Recent Development
  • 16.7. Illumina, Inc.
    • 16.7.1. Company Overview
    • 16.7.2. Financial Performance
    • 16.7.3. Product Benchmarking
    • 16.7.4. Recent Development
  • 16.8. Invitae Corporation
    • 16.8.1. Company Overview
    • 16.8.2. Financial Performance
    • 16.8.3. Product Benchmarking
    • 16.8.4. Recent Development
  • 16.9. Novo Nordisk A/S
    • 16.9.1. Company Overview
    • 16.9.2. Financial Performance
    • 16.9.3. Product Benchmarking
    • 16.9.4. Recent Development
  • 16.10. Quest Diagnostics
    • 16.10.1. Company Overview
    • 16.10.2. Financial Performance
    • 16.10.3. Product Benchmarking
    • 16.10.4. Recent Development

List of Tables

  • Table 1 Global Rare Disease Diagnostics Market, by Disease Type, by Region, 2019-2032 (USD Million)
  • Table 2 Global Rare Disease Diagnostics Market, by Technology, by Region, 2019-2032 (USD Million)
  • Table 3 Global Rare Disease Diagnostics Market, by Mode of Product Type, by Region, 2019-2032 (USD Million)
  • Table 4 Global Rare Disease Diagnostics Market, by Test, by Region, 2019-2032 (USD Million)
  • Table 5 Global Rare Disease Diagnostics Market, by Sample Type, by Region, 2019-2032 (USD Million)
  • Table 6 Global Rare Disease Diagnostics Market, by Age Group, by Region, 2019-2032 (USD Million)
  • Table 7 Global Rare Disease Diagnostics Market, by Trait Type, by Region, 2019-2032 (USD Million)
  • Table 8 Rare Disease Diagnostics Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 9 North America: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
  • Table 10 North America: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • Table 11 North America: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
  • Table 12 North America: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
  • Table 13 North America: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
  • Table 14 North America: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
  • Table 15 North America: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • Table 16 U.S.: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
  • Table 17 U.S.: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • Table 18 U.S.: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)